Navigation Links
Youth Impacted By Recent 'Mitchell Report' on Major League Baseball Steroid Abuse
Date:12/14/2007

t we educate our children and make sure they understand that anabolic steroid use for the sole purpose of winning the game is cheating, is dangerous and is wrong," said Congressman Elijah E. Cummings.

REPORTER/EDITOR NOTE: Powered by ME! has panels of community and medical experts available to speak on the topic of the abuse of steroids by athletes and the impact on youth. Other Powered by ME! founding partners include Orthopaedic Associates, Towson Sports Medicine, The Center for Eating Disorders at Sheppard Pratt, Baltimore Blast and St. Agnes HealthCare. Also a blue ribbon panel of volunteer experts who represent coaches, teachers, parents, athletes and medical professionals has been established to support the educational program

St. Joseph Medical Center is a 374-bed nonprofit, regional medical center in Towson, Maryland, and a member of Catholic Health Initiatives. Founded in 1864 by the Sisters of St. Francis, today St. Joseph Medical Center's specialty centers include the Orthopaedic Institute, Heart Institute, and Cancer Institute. For more information about St. Joseph Medical Center, visit http://www.sjmcmd.org.


'/>"/>
SOURCE St. Joseph Medical Center
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. More than two-thirds of sexually active NYC youth use condoms, but other forms of birth control lag
2. Study documents rapid increase in youth bipolar disorder diagnoses
3. Rates of bipolar diagnosis in youth rapidly climbing, treatment patterns similar to adults
4. Youth Drug Use at a Five Year Low, New Survey Shows
5. Jump in Youth Suicide Prompts National Childrens Charity KidsPeace to Issue Tips on Prevention, Warning Signs
6. ARIZONA METH PROJECT Unveils Arizonas Anti-Meth Youth Pledge and Kicks Off Phase Two of Public Awareness Campaign
7. $8,000 Winning Bids at Governors Livestock Auction to Benefit College-Bound Youth and Homeless
8. Nourishment Is Essential to a Youthful Appearance. Time to Feed Your Face with Serum_G
9. Prime Access Creates Groundbreaking Ads Targeting Urban Teens for the White Houses National Youth Anti-Drug Media Campaign
10. Safe Blood for Africa Foundations African Club 25 Greatly Reducing HIV Infections in African Youth
11. Victims of child maltreatment more likely to perpetrate youth violence, intimate partner violence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2008)...ve prism glasses can significantly improve the vis...a, a condition that blinds half the visual field i...ere invented by Dr. Eli Peli, a Senior Scientist a...in the first community-based multi-center trial of...e of the Archives of Ophthalmology. The study was...
(Date:5/12/2008)... impact and other influences are limiting the grow...laims, CHICAGO, May 12 /PRNewswire-FirstCall/ -- ...r of global risk management and consulting service...long term care industry,finding for the first tim...are stable on a national average basis., (Logo: ...
(Date:5/12/2008)...Newswire-USNewswire/ -- Effective May 19, the Texa...e association will occupy,two full floors at 1108 ..., "Through a partnership with the Texas Automob...THA was able to join a sound real estate venture,t...M.D., FACP, FACHE,president/CEO of THA. "This mov...
(Date:5/12/2008)...iors to compete in sports and games throughout the...PHIA, May 12 /PRNewswire/ -- May is Older American...n cosponsor the Senior Games, held at,dozens of lo...gion. The,games are usually a week long, and take ...onday, May 12 and continuing through the month of ...
Breaking Medicine News(10 mins):Health News:Prism glasses expand the view for patients with hemianopia 2Health News:Prism glasses expand the view for patients with hemianopia 3Health News:Aon Study Finds Stability in Nationwide Liability Costs in the Long Term Health Care Sector 2Health News:Aon Study Finds Stability in Nationwide Liability Costs in the Long Term Health Care Sector 3Health News:Hospital Association Moves Headquarters to Downtown Austin 2Health News:Independence Blue Cross Supports 2008 Senior Games 2
... that the health providers do not treat patients w...hey are not provided with correct diagnosis and tr...e than 1,000 men with prostate cancer and the stud... they were given their diagnosis insensitively. T...
...avier Menendez and colleagues from Northwestern Un...ening primrose oil with Herceptin drug found to be...About 30% of breast cancer patients have Her-2/neu...r type 2), which are severe kind of breast cancer ...
...controversy has surrounded The Thiruvananthapuram ... a one-year-old girl who had received a transfusio...itive for HIV infection. // According to the inqu...sitive, was given blood, which had been taken from...
...opulation is exposed to both natural and artificia... other defects. Strangely, the same radiation that...cancer, //referred to as radiotherapy. It is howev...cise dose of radiation is being delivered. New se...
Other Medicine News:Health News:Prostate cancer patients not happy with health providers 2Health News:Primrose oil reduces Breast cancer cell growth 2Health News:New sensors developed to predict effectiveness of radiotherapy treatment 2
(Date:5/8/2008)...- Globus Medical, Inc., the largest,p...orld and a recognized,leader in motion preservatio...rollment in its SECURE(R)-C Cervical Artificial Di...o mimic the normal motion of the spine in,order to...tive to fusion in,the treatment of symptomatic cer...
(Date:5/8/2008)...ated significant improvement in ADHD symptoms in a...- Shire plc (LSE: SHP,Nasdaq: SHPGY), the global ...ed the results of a phase III pivotal study in whi...n Attention Deficit Hyperactivity,Disorder (ADHD) ...,endpoints., "Adults with ADHD often find it chal...
(Date:5/8/2008)...ay 8 /- Alpharma Inc. (NYSE...y, today announced results from,clinical trials th...tended-release with sequestered naltrexone hydroch...features addressing abuse liability,alongside a pr...nd II,studies, presented at the 27th Annual Scient...
(Date:5/8/2008)...ides "Blueprint" to Produce Therapeutic Proteins a...RNewswire-USNewswire/ -- Using gene,therapy, plast...s through,skin flaps placed on cancerous tumors on... according to a study in the May issue of Plastic ...l journal of the American,Society of Plastic Surge...
Breaking Medicine Technology:Globus Medical Completes Enrollment Of SECURE(R)-C Cervical Artificial Disc Clinical Trial 2Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 2Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 3Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 4Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 5Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 2Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 3Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 4Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 5Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 6Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 7Skin Flaps Deliver Cancer-fighting Therapy, ASPS Study Reveals 2Skin Flaps Deliver Cancer-fighting Therapy, ASPS Study Reveals 3Tree of life for flowering plants reveals relationships among major groups 1339 1Tree of life for flowering plants reveals relationships among major groups 1339 2Wackenhut Enhances Health Insurance Plans Without Raising Costs 6943 1Wackenhut Enhances Health Insurance Plans Without Raising Costs 6943 2Flextronics to Report Third Quarter Results 6938 1Flextronics to Report Third Quarter Results 6938 2Digital Healthcare Announces Cincinnati Eye Institute is Latest Retasure Reading Center 1953 1Digital Healthcare Announces Cincinnati Eye Institute is Latest Retasure Reading Center 1953 2
... 19, 2007 - ACADIA Pharmaceuticals,Inc. (Nasdaq:AC...,its Phase II schizophrenia co-therapy trial with ... inverse agonist. The trial,evaluated ACP-103 co-t... a commonly prescribed atypical antipsychotic drug...drug. The co-therapy,arms with ACP-103 demonstrate...
...ewswire-FirstCall/ -- La Jolla,Pharmaceutical Comp...tion data for the Phase 3 trial of Riquent(R) (abe...us erythematosus,("lupus" or "SLE"). The updated a...re is a definitive and significant dose response,b...ent compared,with placebo (p=0.0001). These interi...
Other Medicine Technology:Acadia Announces Positive Results From ACP-103 Phase II,Schizophrenia Co-Therapy Trial 2Acadia Announces Positive Results From ACP-103 Phase II,Schizophrenia Co-Therapy Trial 3Acadia Announces Positive Results From ACP-103 Phase II,Schizophrenia Co-Therapy Trial 4Acadia Announces Positive Results From ACP-103 Phase II,Schizophrenia Co-Therapy Trial 5Acadia Announces Positive Results From ACP-103 Phase II,Schizophrenia Co-Therapy Trial 6La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial 2La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial 3La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial 4La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial 5La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial 6
Hardy Curettes, bayonet, working distance 4 3/4" (120 mm), total length 9 1/2" (241 mm), tip width 3 mm.
PG Magnum Ring Curettes, total length 12.6" (32 cm), handle length 7.8" (20 cm), handle diameter 1.12" (3 cm), working distance 4.7" (12 cm), dual-coned, precision sharpened rings.
Karlin Cervical Microdiscectomy Curette, length 8 1/2" (21 cm).
Caspar Curette, 250 mm, 10".
Medicine Products: